Catalyst

Slingshot members are tracking this event:

First Patient Enrolled in Phase 3 COMET Study Evaluating Sanofi's (SNY) NeoGAA in Treatment of Pompe Disease

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
SNY

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 17, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Comet, Phase 3, Neogaa, Pompe Disease